← Back

Center Laboratories

30.80-2.7%1Y · TWD

Center Laboratories, Inc. is a pharmaceutical company that develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. Its product portfolio includes general medications such as antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. The company also offers central nervous system medications for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease. Founded in 1959, Center Laboratories is headquartered in Taipei, Taiwan.

Price · split & dividend adjusted
News & notes moving 4123.TWO
United StatesJapanUnited Kingdom
Digital Finance & Tokenization

Strategy pushes back on new MSCI delisting threat

Strategy, the Bitcoin treasury company led by Michael Saylor, faces a fresh MSCI delisting threat after the index provider opened a consultation on the eligibility of non-operating companies for its Global Investable Market Indexes. A simulation using May 2026 data shows Strategy, Metaplanet, and Yellow Cake could be deleted from the MSCI ACWI IMI, while SharpLink, Center Laboratories, and Lydia Holding would be placed on a watchlist. MSCI's proposed framework would exclude companies that fail an initial operating-asset test and trigger at least four of five financial flags, including operating assets below 20% of total assets and negative operating cash flow. Strategy, with a free-float-adjusted market cap of $23.9 billion in the simulation, is the largest company that could be removed, and the company responded on X saying index providers should measure markets, not decide which assets companies are allowed to own. MSCI is gathering feedback through September 30 and expects to announce results by October 16.
About megatrends
Digital Finance & Tokenization › Bitcoin / Crypto Treasury & Store-of-Value Proxies ▼Regulation
MSTR · Regulation · Negative MSCI consultation could delete Strategy from indexes due to non-operating asset rules.
3350.JP · Regulation · Negative Metaplanet could be deleted from MSCI ACWI IMI under new rules.
YCA.LSE · Regulation · Negative Simulation shows Yellow Cake could be deleted from MSCI ACWI IMI.
4123.TWO · Regulation · Neutral Placed on watchlist under MSCI's proposed framework, but impact unclear.
SBET · Regulation · Neutral Placed on watchlist under MSCI's proposed framework, but impact unclear.
Read original ↗
TheStreet·52dRead more →